At a Glance: Prescribing Information for HCV Treatments

Download this practical reference sheet on all the FDA-approved regimens for treating hepatitis C virus.
Format: Adobe Acrobat (.pdf)
File Size: 47 KB
Released: September 26, 2017

Acknowledgements

Educational grant provided by:
Gilead Sciences

Related Content

Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)

Tarik Asselah, MD, PhD Stefan Zeuzem, MD Released: July 6, 2022

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis

person default Sherry Tierney Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 17, 2022 Expired: May 16, 2023

Clinical Care Options (CCO) commentary from Oluwaseun Falade-Nwulia, MBBS, MPH, on the need for integrating HCV services into addiction medicine settings

Oluwaseun Falade-Nwulia, MBBS, MPH Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 30, 2022 Expired: March 29, 2023

Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who has lived with and been cured of HCV infection

person default Shelley Rossell Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: March 24, 2022 Expired: March 23, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings